secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIZYME, INC. (—)
CIK:        0001413754
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001493152-25-009077
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Marizyme restates Q1 and Q2 2024 results; non-reliance due to convertible note accounting errors
--------------------------------------------------------------------------------

- Non-reliance on financial statements for quarters ended March 31, 2024 and June 30, 2024 due to misstatements.
- Convertible note modifications incorrectly recorded debt discount amortization instead of loss on extinguishment.
- Material weakness identified in internal controls over debt/equity transactions; controls not effective.
- Restatement to be included in September 30, 2024 Form 10-Q; no impact on cash, revenues, or liquidity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413754/000149315225009077/0001493152-25-009077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413754/000149315225009077/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer